ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1993–2004 of 2020 project topics
CF Lung Disease Modifier Gene Identification
Conducting GWAS in CF patients for identifying genetic modifiers of lung disease progression including TGFB1, MUC5B, and HLA region variants.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
CFTR Related Metabolic Syndrome Genetics
Studying CFTR variant spectrum in CRMS/CFSPID and newborn-screened infants for predicting progression to clinical CF diagnosis.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
CFTR Variant Classification SaaS Platform Enterprise
A cloud-based diagnostic platform that classifies rare and novel CFTR mutations using machine learning algorithms and functional prediction models to support clinical decision-making. The platform generates revenue through subscription licensing to genetic testing laboratories, enabling faster turnaround times and improved diagnostic accuracy for CF patients.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
CF Pancreatic Insufficiency Risk Prediction Engine
A predictive analytics tool that integrates CFTR genotype data with clinical biomarkers to identify CF patients at highest risk for pancreatic complications. The service creates revenue opportunities through partnerships with clinical care networks, insurance companies, and personalized treatment providers seeking risk stratification solutions.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
High-Throughput CFTR Functional Testing Laboratory Service
A commercial laboratory service that performs functional assays on CFTR variants using cell-based and organoid models to determine protein trafficking and channel activity. The service monetizes through testing fees charged to pharmaceutical companies, genetic testing laboratories, and clinical researchers validating novel therapeutic targets.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
Polygenic Risk Score Development Kit CFTR Complications
A bioinformatics toolkit and software suite that enables development of polygenic risk scores predicting CF-related complications including liver disease, bone mineral density loss, and CF-related diabetes. This platform generates revenue through licensing agreements with genomic research institutions, precision medicine companies, and healthcare systems implementing population-level risk screening.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
CFTR Mutation Database and Commercial Annotation API
An enterprise-grade, regularly updated CFTR variant database with API access providing functional annotations, population frequency data, and therapeutic response predictions curated from published literature. The database monetizes through tiered API subscription models serving clinical laboratories, pharmaceutical companies, and health technology vendors integrating variant interpretation workflows.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
Airway Epithelial Genetic Modifier Screening Technology
An innovative diagnostic test that sequences modifier genes in airway epithelial tissue samples to identify genetic factors influencing CFTR expression and CF disease severity variability. The technology captures revenue through direct-to-clinic testing services and licensing agreements with pharmaceutical companies developing personalized CF therapeutics and precision dosing protocols.
Genetic Basis of Cystic Fibrosis Advanced Topics Click to view more details →
Pangenome Reference and Variant Discovery
Using the human pangenome reference for improving variant discovery in structurally complex regions and diverse population genomes.
Future Directions in Human Genetics Click to view more details →
AI-Assisted Variant Interpretation Development
Developing and validating large language model and machine learning tools for improving clinical variant interpretation accuracy and efficiency.
Future Directions in Human Genetics Click to view more details →
Single Molecule Sequencing for Epigenomics
Applying fourth generation single molecule sequencing for simultaneous base modification and sequence determination for comprehensive epigenomic disease characterization.
Future Directions in Human Genetics Click to view more details →
Spatial Genomics for Tissue Gene Regulation
Applying spatial omics technologies for mapping genetic variant effects in tissue context for understanding cell type-specific regulatory mechanisms.
Future Directions in Human Genetics Click to view more details →